COVID 19 RT-qPCR - India CDSCO Medical Device Registration
COVID 19 RT-qPCR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000049_1eae2ccdc4b0a1107f727d89bd14a90b_a64e8fb5d4205787b15eecc5df4f4528. This device is marketed under the brand name ProPCR. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
ProPCR
License Holder
Promea Therapeutics Private LimitedDevice Class
Approving Authority
CDSCO, Zonal office, Hyderabad
Product Information
It is used to detect target gene amplification through gene specific primers and probes by using Taq Man Chemistry Method
TRIPLEX HBV/HCV/HIV RT-PCR
Inactivation Transport Medium
Nucleic Acid Extraction Kit
Brand: ProPCR
Blood Glucose Meter Smart - GDH
Brand: P. falciparum, histidine-rich protein II
Dengue NS1 Rapid
HBsAg Rapid Kit
Brand: IgG and IgM
Blood Glucose Meter- GDH
Brand: P. falciparum, histidine-rich protein II
Blood Glucose Meter- GOD
Brand: P. falciparum, histidine-rich protein II
Blood Glucose Meter Smart - GOD
Brand: P. falciparum, histidine-rich protein II